l 163191 has been researched along with lisinopril in 1 studies
Studies (l 163191) | Trials (l 163191) | Recent Studies (post-2010) (l 163191) | Studies (lisinopril) | Trials (lisinopril) | Recent Studies (post-2010) (lisinopril) |
---|---|---|---|---|---|
35 | 0 | 17 | 2,210 | 648 | 491 |
Protein | Taxonomy | l 163191 (IC50) | lisinopril (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Homo sapiens (human) | 0.0021 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.287 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.0012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Patchett, AA | 1 |
1 other study(ies) available for l 163191 and lisinopril
Article | Year |
---|---|
2002 Alfred Burger Award Address in Medicinal Chemistry. Natural products and design: interrelated approaches in drug discovery.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Awards and Prizes; Benzodiazepinones; Biological Products; Chemistry, Organic; Drug Design; History, 20th Century; History, 21st Century; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; United States | 2002 |